| Bioactivity | Carcinoembryonic Antigen (CEA) is a tumor marker in lung cancer. | ||||||
| Invitro | Carcinoembryonic Antigen (CEA) as tumor marker in lung cancer. The use of CEA as a prognostic and predictive marker. CEA is a glycoprotein involved in cell adhesion, and is normally produced during fetal development but the production stops before birth. CEA is a glycosyl phosphatidyl inositol (GPI)-cell surface anchored glycoprotein whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells[1]. | ||||||
| Name | Carcinoembryonic Antigen (CEA) | ||||||
| CAS | 168635-85-6 | ||||||
| Sequence | Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu | ||||||
| Shortening | YLSGANLNL | ||||||
| Formula | C43H69N11O14 | ||||||
| Molar Mass | 964.07 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture and light
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) |